Saturday, July 13, 2013

Just when you thought the RNL Bio saga could not get any stranger...

It does.  A Korean newspaper is reporting that Dr. Jeong Chan Ra, the CEO of the embattled stem cell company, has been arrested for insider trading.  RNL Bio has been delisted from the Korean Stock Exchange, and apparently, Ra is also accused of sexual harassment. Meanwhile, its European subidiary, RNL Europe, has become insolvent.  RNL Europe, you may recall, was headed up by former American Journal of Bioethics editor, Glenn McGee.

Read about the whole sordid affair on Leigh Turner's "Health in the Global Village" blog.

No comments:

Post a Comment